Insider Transactions in Q3 2025 at Johnson & Johnson (JNJ)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2025
|
Joseph J Wolk Exec VP, CFO |
SELL
Open market or private sale
|
Direct |
16,820
-54.58%
|
$2,960,320
$176.91 P/Share
|
|
Aug 15
2025
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,820
+35.31%
|
$1,698,820
$101.87 P/Share
|
|
Jul 17
2025
|
John C Reed EVP, Innovative Medicine, R&D |
SELL
Open market or private sale
|
Direct |
19,137
-64.23%
|
$3,119,331
$163.55 P/Share
|